FDA.reportPublic FDA data

EZETIMIBE

Substance profile for UNII EOR26LQQ24, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for EZETIMIBE
Structure render from PubChem CID 150311

Substance Identity#

UNII
EOR26LQQ24
Preferred term
EZETIMIBE
Registry number
163222-33-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C24H21F2NO3
Chemical structure for EZETIMIBE
Structure render from PubChem CID 150311

Chemical And Database Identifiers#

InChIKey
OLNTVTPDXPETLC-XPWALMASSA-N
SMILES
O[C@@H](CC[C@@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
RxCUI
341248
PubChem
150311
NCIt
C47529
INN ID
8010

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound150311https://pubchem.ncbi.nlm.nih.gov/compound/150311
PubChem InChIKey SearchOLNTVTPDXPETLC-XPWALMASSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=OLNTVTPDXPETLC-XPWALMASSA-N
RxNorm341248https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=341248
NCI ThesaurusC47529https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47529
FDA Substance Registration SystemEOR26LQQ24https://precision.fda.gov/uniisearch/srs/unii/EOR26LQQ24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ezetimibeACTIVE MOIETYEOR26LQQ24These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. VYTORIN® (ezetimibe/simvastatin) Tablets Initial U.S. Approval: 20042
ezetimibeACTIVE INGREDIENTEOR26LQQ24These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. VYTORIN® (ezetimibe/simvastatin) Tablets Initial U.S. Approval: 20042
EzetimibeACTIVE MOIETYEOR26LQQ24These highlights do not include all the information needed to use ZETIA safely and effectively. See full prescribing information for ZETIA. ZETIA (ezetimibe) Tablets Initial U.S. Approval: 20021
EzetimibeACTIVE INGREDIENTEOR26LQQ24These highlights do not include all the information needed to use ZETIA safely and effectively. See full prescribing information for ZETIA. ZETIA (ezetimibe) Tablets Initial U.S. Approval: 20021
ezetimibeACTIVE INGREDIENTEOR26LQQ24These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. VYTORIN (ezetimibe/simvastatin) Tablets Initial U.S. Approval: 20041
ezetimibeACTIVE MOIETYEOR26LQQ24These highlights do not include all the information needed to use VYTORIN safely and effectively. See full prescribing information for VYTORIN. VYTORIN (ezetimibe/simvastatin) Tablets Initial U.S. Approval: 20041
EZETIMIBEACTIVE INGREDIENTEOR26LQQ24These highlights do not include all the information needed to use ZETIA safely and effectively. See full prescribing information for ZETIA. ZETIA (ezetimibe) Tablets Initial U.S. Approval: 20022
EZETIMIBEACTIVE MOIETYEOR26LQQ24These highlights do not include all the information needed to use ZETIA safely and effectively. See full prescribing information for ZETIA. ZETIA (ezetimibe) Tablets Initial U.S. Approval: 20022
EzetimibeACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3675
EzetimibeACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3675
EZETIMIBEACTIVE MOIETYEOR26LQQ24VYTORIN (EZETIMIBE SIMVASTIN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]400
EZETIMIBEACTIVE INGREDIENTEOR26LQQ24VYTORIN (EZETIMIBE SIMVASTIN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]400
EZETIMIBEACTIVE INGREDIENTEOR26LQQ24VYTORIN (EZETIMIBE/SIMVASTIN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]369
EZETIMIBEACTIVE MOIETYEOR26LQQ24VYTORIN (EZETIMIBE/SIMVASTIN) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]369
ezetimibeACTIVE INGREDIENTEOR26LQQ24VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [MERCK SHARP & DOHME CORP.]43
ezetimibeACTIVE MOIETYEOR26LQQ24VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [MERCK SHARP & DOHME CORP.]43
ezetimibeACTIVE MOIETYEOR26LQQ24VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [PD-RX PHARMACEUTICALS, INC.]24
ezetimibeACTIVE INGREDIENTEOR26LQQ24VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [PD-RX PHARMACEUTICALS, INC.]24
ezetimibeACTIVE INGREDIENTEOR26LQQ24VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [PD-RX PHARMACEUTICALS, INC.]22
ezetimibeACTIVE MOIETYEOR26LQQ24VYTORIN (EZETIMIBE AND SIMVASTATIN) TABLET [PD-RX PHARMACEUTICALS, INC.]22
EzetimibeACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [MERCK SHARP & DOHME CORP.]14
EzetimibeACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [MERCK SHARP & DOHME CORP.]14
EZETIMIBEACTIVE MOIETYEOR26LQQ24LIPTRUZET (EZETIMIBE AND ATORVASTATIN) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]6
EZETIMIBEACTIVE INGREDIENTEOR26LQQ24LIPTRUZET (EZETIMIBE AND ATORVASTATIN) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.]6
EzetimibeACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [CARDINAL HEALTH]5
EzetimibeACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [CARDINAL HEALTH]5
EzetimibeACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [CARDINAL HEALTH]2
EzetimibeACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [CARDINAL HEALTH]2
EZETIMIBEACTIVE INGREDIENTEOR26LQQ24EZETIMIBE TABLET [GLENMARK GENERICS INC., USA]1
EZETIMIBEACTIVE MOIETYEOR26LQQ24EZETIMIBE TABLET [GLENMARK GENERICS INC., USA]1
EZETIMIBEACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [A-S MEDICATION SOLUTIONS LLC]1
EZETIMIBEACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [A-S MEDICATION SOLUTIONS LLC]1
EzetimibeACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [CARDINAL HEALTH]1
EzetimibeACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [CARDINAL HEALTH]1
EZETIMIBEACTIVE MOIETYEOR26LQQ24ZETIA (EZETIMIBE) TABLET [REMEDYREPACK INC. ]1
EzetimibeACTIVE INGREDIENTEOR26LQQ24ZETIA (EZETIMIBE) TABLET [REMEDYREPACK INC. ]1